Mirum Pharmaceuticals (MIRM) Q2 2026 Earnings

6MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-13.43
-8.94
-4.44
0.05

Details

Expected EPS
-0.365267
Actual EPS
-13.43
Surprise EPS
-13.06
Surprise Percent
+3,576.76%

Description

Mirum Pharmaceuticals (MIRM) has reported earnings of -13.43 per share for Q2 2026.

0 Comments

Share your thoughts